Results depend on factors such as adherence to the program and individual metabolic factors
Some patients report late-day hunger returning before their next dose
Fifth is essential to mitochondrial function, and we all know the mitochondria are the powerhouse of the cell
This dual burden emphasizes the need for therapeutic strategies that extend beyond localized skin treatments
This dual GIP/GLP-1 receptor agonist, approved by the FDA for type 2 diabetes and chronic weight management, may cause dizziness through several mechanisms including dehydration from gastrointestinal side effects, medication interactions affecting blood pressure, hypoglycemia when combined with insulin or sulfonylureas, and orthostatic hypotension related to weight loss
The combined effect of appetite suppression, increased energy, and fewer cravings creates a more favorable environment for weight loss or weight stability, especially compared to other antidepressants that may promote weight gain